Literature DB >> 8197548

[The methods and results of simultaneous radiochemotherapy with carboplatin in advanced cervical carcinomas].

A Brock1, W Prager, R Böhme, S Pohlmann.   

Abstract

PURPOSE: The frequency and the poor therapeutic results in advanced cervical cancer establish the demand for effectiveness of treatment. Recent clinical data have shown that simultaneous radiochemotherapy may yield high remission rates in squamous cell carcinomas of other organs. PATIENTS AND METHODS: In our Department of Radiotherapy and Radiooncology of the University of Leipzig we treated since 1.6.1991 17 patients with advanced cancer of the uterine cervix with a simultaneous radiochemotherapy with carboplatin.
RESULTS: The rate of complete remission was 76%. Follow-up is available from six to 24 months. Severe or toxic side effects of the treatment we didn't observe. Eight (47%) patients live relapse-free.
CONCLUSIONS: In our opinion randomized studies are required to determine: What is better? Simultaneous radiochemotherapy or radiotherapy?

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8197548

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  2 in total

1.  [Radiotherapy and carboplatin in cervix cancer].

Authors:  J Dunst
Journal:  Strahlenther Onkol       Date:  1998-02       Impact factor: 3.621

2.  Gemcitabine and carboplatin demonstrate synergistic cytotoxicity in cervical cancer cells by inhibiting DNA synthesis and increasing cell apoptosis.

Authors:  Guixiu Jin; Jing Zhao; Hongyan Qi; Meng Lou; Xia Liu; Yu Qu; Lingjun Zhao; Weifeng Zhang; Jimin Shao; Huizhen Zhong
Journal:  Onco Targets Ther       Date:  2013-11-25       Impact factor: 4.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.